InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: David Fowler post# 87158

Wednesday, 04/09/2014 2:43:29 PM

Wednesday, April 09, 2014 2:43:29 PM

Post# of 146235
Seymour hasn't had anything to do with the management of Saliva Diagnostics in years. Same with Ehrlich. As a matter of fact, Ehrlich brought a company out of near bankruptcy that now has three ongoing human trials.

Shareholders here would do very well with the initiation of human trials. Seymour may yet pull it off. Time will tell.




In Reply to 'David Fowler'
Wise UP! The future of NNVC:

Eugene Seymour and Leo Ehrlich's previous company "Saliva Diagnostics" seems to have essentially gone straight to zero and appears to have received law suits and multiple FDA warning letters5. This defunct company now trades with ticker SSUR for $0.05 per share with $198k market cap (not a typo).




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News